Discuss Abbott Laboratories
Abbott Laboratories
WKN: 850103 / Symbol: ABT / Name: Abbott / Aktie / Pharmazeutika / Large Cap /
90,86 €
-1,34 %
Abbott Laboratories (NYSE:ABT) had its price target raised by analysts at Sanford C. Bernstein from $150.00 to $154.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $157.00 to $152.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at Piper Sandler from $150.00 to $135.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at BTIG Research from $145.00 to $140.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at Evercore ISI from $144.00 to $138.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at Raymond James Financial, Inc. from $146.00 to $130.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $152.00 to $140.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $140.00 to $132.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at Royal Bank Of Canada from $147.00 to $135.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at Sanford C. Bernstein from $154.00 to $125.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at Citigroup Inc. from $155.00 to $140.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Neueste Beiträge
JPMorgan_Chase___Co_ in Intel Corp. diskutieren